Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics (PK) and safety of multiple doses of
lumacaftor in combination with ivacaftor in subjects with moderate hepatic impairment.